ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
高瓴概念
470.464
+14.502
3.18%
手動刷新
漲家數:
41
跌家數:
11
平家數:
3
市盈率:
- -
高:
471.732
開:
456.195
低:
454.105
收:
455.962
成交量:
7.13億
成交額:
287.07億
市值:
2.85萬億
流通市值:
2.11萬億
資料載入中...
總覽
新聞資訊
金磚五國:3月25日股匯市收盤縱覽
路透中文
·
1小時前
愛康醫療(01789)發布年度業績 股東應占年度溢利3.39億元 按年增加23.8%
智通财经
·
昨天
先聲藥業(02096)附屬擬3076.32萬元收購上海先聲診斷技術全部股權 旨在打造開放式創新交流中心
智通财经
·
昨天
先聲藥業(02096):麥寶文獲委任為聯席公司秘書
智通财经
·
昨天
先聲藥業(02096):周雲曙獲委任為首席執行官
智通财经
·
昨天
水泥行業持續低迷,海螺水泥何以盈利81億,實現五年首增?
澎湃新闻
·
昨天
融創服務:2026年6月9日派發股息0.01元/股
南方财经网
·
昨天
融創服務(01516)發布年度業績 股東應占利潤2.03億元 按年扭虧為盈
智通财经
·
昨天
沛嘉醫療-B(09996)發布年度業績 收入按年增長15.82%至7.13億元 神經介入業務分部利潤按年大幅增長86.6%
智通财经
·
昨天
沛嘉醫療-B:2026年或成集團神經介入業務全球化擴張的起點
美股速递
·
昨天
3月25日海螺水泥發布公告,股東增持3475.56萬股
中金财经
·
昨天
李氏大藥廠(00950):茵若颯取得國家藥監局批准
智通财经
·
昨天
兆科眼科-B(06622)公布2025年業績 税後虧損約2.09億元 按年收窄12%
智通财经
·
昨天
Zhaoke Ophthalmology FY2025; revenue drops to CNY 32 million due to lower one-off license income
Reuters
·
昨天
「三甲」之後,險資辦醫的「下半場」:不拼床位拼什麼?
每日经济新闻
·
昨天
歸創通橋(02190)3月25日耗資約189.24萬港元回購7.9萬股
智通财经
·
昨天
泰凌醫藥(01011)完成收購浙江康源醫療器械58.11%股權
智通财经
·
昨天
仁橋(北京)資產管理有限公司增持紅星美凱龍(01528)756.28萬股 每股作價約1.24港元
智通财经
·
昨天
執行董事龍振國增持德琪醫藥(06996)23.5萬股 每股作價約4.14港元
智通财经网
·
昨天
資金動向 | 北水淨買入港股223億港元,大手筆加倉泡泡瑪特、美團和阿里
格隆汇
·
昨天
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1583/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":470.46436,"timestamp":1774426110396,"preClose":455.9619,"halted":0,"volume":713286572,"delay":0,"changeRate":0.031806,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":14.502441,"latestTime":"03-25 16:00:00","open":456.19492,"high":471.73242,"low":454.10455,"amount":28707499287,"amplitude":0.038661,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774488600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1774402200000,1774411200000],[1774414800000,1774425600000]],"pbRate":2.138966,"peRate":31.744397,"turnoverRate":0.004966,"increases":40,"decrements":12,"flats":0,"marketCap":2849023314976,"floatMarketCap":2110368466464},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":471.73242,"amplitude":0.038661,"preClose":455.9619,"low":454.10455,"pbRate":"2.138966","latestPrice":470.46436,"volume":713286572,"delay":0,"open":456.19492,"prevYearClose":503.90085,"prevWeekClose":456.189,"prevMonthClose":490.497,"prevQuarterClose":503.901,"fiveDayClose":470.823,"twentyDayClose":504.87,"sixtyDayClose":517.33,"secType":"PLATE","market":"HK","turnoverRate":0.004966,"peRate":31.744397,"marketCap":2849023314976,"floatMarketCap":2110368466464,"timestamp":1774426110396,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":41,"down":11,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622000011","title":"金磚五國:3月25日股匯市收盤縱覽","url":"https://stock-news.laohu8.com/highlight/detail?id=2622000011","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622000011?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 06:20","pubTimestamp":1774477230,"startTime":"0","endTime":"0","summary":"金砖五国:3月25日股汇市收盘纵览路透3月26日 - 以下为“金砖国家”-中国、印度、俄罗斯、巴西和南非主要股市指数及货币3月25日(周三)走势纵览。MSCI新兴市场指数.MSCIEF收盘上涨28.68点,或1.99%,报1,472.58点。BSE指数.BSESN收盘上涨1,205.00点,或1.63%,报75,273.45;NSE指数.NSEI收盘上涨394.05点,或1.72%,报23,306.45点。nL4N40D0IS.BO印度汇市:卢比兑美元INR=ININR=D2收报93.9775卢比,上日收报93.865。美国祭出最新制裁后,莫斯科交易所停止美元和欧元交易,主要货币的交易转移到场外交易市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL6T40D1FR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0577902611.USD","IE00B543WZ88.USD","LU2778985437.USD","LU0326948709.USD","LU1868837565.USD","LU0251144936.SGD","LU1808992512.USD","LU0149721374.USD","LU0348825331.USD","BK1589","LU0540923850.HKD","LU0039217434.USD","LU2097828805.USD","LU0633140727.USD","LU1242518931.SGD","SG9999002828.SGD","LU0823426480.USD","LU0359201885.HKD","LU1048596156.SGD","LU0269904917.USD","LU0106252389.USD","LU0499858602.USD","LU1794554557.SGD","LU0049853897.USD","LU0054450605.USD","LU0348735423.USD","LU0499858438.USD","LU0244354667.USD","LU1770034418.SGD","LU2097828557.USD","LU0029875118.USD","LU0287142896.SGD","LU0455707207.USD","IE00B5MMRT66.SGD","BK1618","LU1961090484.USD","LU0327786744.USD","LU0828237940.HKD","SG9999002562.SGD","IE0008368742.USD","LU1328615791.USD","LU0128522157.USD","LU2148510915.USD","LU1720050803.USD","LU0737861699.HKD","LU0314109678.HKD","LU2257852520.SGD","SG9999002463.SGD","LU0320764599.SGD","BK1610","LU0531971595.HKD","LU0047713382.USD","LU0449515922.USD","LU0541502299.USD","LU0588545490.SGD","LU0165289439.USD","LU0708995583.HKD","LU0823038988.USD","LU1152091754.HKD","LU2045819591.USD","LU0572944931.SGD","LU0051755006.USD","LU1048588211.SGD","LU0054237671.USD","LU1282648689.USD","LU1303224171.USD","LU1770036033.HKD","LU0210526637.USD","LU0348816934.USD","LU1102505929.USD","LU0214875030.USD","LU0370786039.SGD","BK1583","LU1105468828.SGD","LU1251922891.USD","LU0048580855.USD","LU2476274308.USD","IE00B3M56506.USD","IE00B0JY6N72.USD","LU0873338254.USD","LU0011963245.USD","LU1064130708.USD","LU0181495838.USD","IE0034224299.USD","LU0871576103.HKD","LU0672654166.SGD","LU1102505762.USD","LU0072913022.USD","LU0143863784.USD","LU0431992006.USD","LU1960683339.HKD","LU0880133367.SGD","LU1880383440.USD","LU1064131003.USD","LU2399975544.HKD","LU0196878994.USD","LU0043850808.USD","METmain","LU0918141705.HKD","LU0577902454.USD","SG9999001689.USD","LU0117841782.USD","HMTD.SI","SG9999000327.SGD","LU0315178854.USD","LU0084288322.USD","LU0417516902.SGD","LU1226287529.USD","LU0821914370.USD","LU0072462343.USD","LU0819123356.HKD","IE00BPRC5H50.USD","LU0456846285.SGD","LU0588546209.SGD","LU1734074674.USD","LU1481107354.HKD","LU0348827113.USD","LU0594300419.USD","LU2087589342.USD","LU2097828714.EUR","IE00BF5LJ272.USD","LU0501845795.SGD","LU0683595622.HKD","LU1719994722.HKD","LU0828237510.HKD","LU0865486749.SGD","IE0008369823.USD","LU0320764755.SGD","LU1868837722.USD","LU0577902371.SGD","LU2226246903.HKD","LU0819121731.USD","LU1328277881.USD","IE00B29SXG58.USD","LU1188198961.HKD","SG9999000459.SGD","LU0140636845.USD","LU2097828474.EUR","LU0823426308.USD","BK1521","LU2152927971.USD","LU0594300179.USD","LU0700851271.USD","LU1152091168.USD","LU0611395673.USD","LU0561508036.HKD","LU0589944569.HKD","LU1675838814.USD","LU1831875114.USD","LU0868486357.SGD","LU0588545730.USD","LU1323998911.USD","LU1813983027.USD","LU2125910500.SGD","LU0823040885.USD","LU0979878070.USD","LU0345775950.USD","LU0052750758.USD","LU0173614495.USD","LU0164865239.USD","LU0605514214.HKD","LU0348788117.USD","LU0650527681.SGD","LU0348814723.USD","LU1868838027.USD","BK1604","BK1233","LU0588545904.SGD","LU0359202008.SGD","BK1142","LU0593848301.USD","LU1993786604.SGD","LU2476274720.SGD","LU1807302812.USD","LU0797268264.HKD","SG9999014674.SGD","BK1615","LU0856984785.SGD","LU2039709279.SGD","LU0463099449.HKD","LU0143863198.USD","LU0211977185.USD","LU0164880469.USD","LU2097828631.EUR","LU0348805143.USD","LU0228659784.USD","LU0918141887.USD","LU0541501648.USD","LU0326950275.SGD","LU1008478684.HKD","LU0509642566.USD","LU0449509016.USD","LU0634319403.HKD","LU1224709979.USD","LU0231483743.USD","LU0502904849.HKD","LU0577902538.SGD","LU1880383366.USD","LU0261950983.USD","LU0456827905.SGD","LU0307460666.USD","LU0132412106.USD","LU0828238088.HKD","LU1242518857.USD","LU0048597586.USD","LU0417516738.SGD","LU1023057109.AUD","LU0577902298.EUR","LU0823041008.USD","SG9999001903.USD","IE00B031HY20.USD","LU0067412154.USD","LU0543330483.HKD","LU2242644610.SGD","LU0633140560.USD","LU0823039010.USD","LU2488822045.USD","BK1591","LU0359201612.USD","IE0032431581.USD","BK1575","LU1688375341.USD","LU0345776255.USD","LU0878005551.USD","LU0164872284.USD"],"gpt_icon":1},{"id":"2622703077","title":"愛康醫療(01789)發布年度業績 股東應占年度溢利3.39億元 按年增加23.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622703077","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622703077?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 23:10","pubTimestamp":1774451449,"startTime":"0","endTime":"0","summary":"智通财经APP讯,爱康医疗 发布截至2025年12月31日止年度业绩,该集团取得收入人民币14.82亿元,同比增加10.1%;公司权益股东应占年度溢利3.39亿元,同比增加23.8%;每股基本盈利0.304元,拟派发末期股息每股11.8港仙。2025年,在带量采购政策推动下,进一步加速进口替代,公司产品的手术量需求持续增长。本集团截至2025年12月31日止年度实现净利润人民币 3.39亿元,较2024年同期显著增长23.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419118.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1100","01789","BK1617","BK1585"],"gpt_icon":0},{"id":"2622070832","title":"先聲藥業(02096)附屬擬3076.32萬元收購上海先聲診斷技術全部股權 旨在打造開放式創新交流中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2622070832","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622070832?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 23:10","pubTimestamp":1774451422,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先声药业 发布公告,于2026年3月25日,买方先声药业有限公司与卖方江苏先声诊断技术有限公司订立股权转让协议,买方同意收购而卖方同意出售目标公司上海先声诊断技术有限公司的全部股权,现金代价为人民币3076.32万元。收购事项完成后,目标公司将成为公司的间接全资附属公司,且目标公司的财务业绩将并入集团的财务报表。收购事项旨在打造一个开放式的创新交流中心,该中心是落实创新驱动发展战略的一项重要战略设施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1583","02096"],"gpt_icon":0},{"id":"2622077224","title":"先聲藥業(02096):麥寶文獲委任為聯席公司秘書","url":"https://stock-news.laohu8.com/highlight/detail?id=2622077224","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622077224?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 23:06","pubTimestamp":1774451193,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先声药业(02096)发布公告,黄慧玲女士已辞任公司的联席公司秘书,自2026年3月25日生效。麦宝文女士已获委任为联席公司秘书,自2026年3月25日起生效。万玉山先生将继续出任另一名联席公司秘书。联交所已确认万先生符合联交所上市规则第3.28条所规定,并已具备担任公司的公司秘书资格。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","BK1583","BK1191"],"gpt_icon":0},{"id":"2622772640","title":"先聲藥業(02096):周雲曙獲委任為首席執行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2622772640","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622772640?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 23:02","pubTimestamp":1774450923,"startTime":"0","endTime":"0","summary":"智通财经APP讯,先声药业(02096)发布公告,周云曙博士已获委任为首席执行官,自2026年3月25日起生效。在此职务中,彼作为高级管理人员,负责监督本集团业务营运的整体管理。周博士向董事会汇报,并须接受董事会的指导及监督。为专注集团长期战略制定、重大投资决策及监督董事会履职,任晋生先生将自2026年3月25日起不再担任首席执行官。任先生将继续担任公司董事长兼执行董事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1580142542.USD","LU1997245177.USD","BK1191","BK0239","BK0196","LU2580892862.HKD","LU2097828805.USD","LU0405327494.USD","LU1655091616.SGD","LU2495084118.USD","LU2289578879.USD","LU2148510915.USD","LU2097828714.EUR","LU1064131003.USD","LU1255011170.USD","02096","BK0060","LU1064130708.USD","BK0028","LU1997244956.HKD","BK1583","LU2488822045.USD","BK0183","LU1820825898.SGD","LU1328615791.USD","LU2097828474.EUR","LU1969619763.USD","LU2328871848.SGD","BK0012","LU1997245094.SGD","LU1781817850.SGD","LU2097828557.USD","600276","LU2097828631.EUR","BK0188","LU0405327148.USD","LU1146622755.USD","LU2580892789.USD"],"gpt_icon":0},{"id":"2622779950","title":"水泥行業持續低迷,海螺水泥何以盈利81億,實現五年首增?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622779950","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622779950?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 22:46","pubTimestamp":1774449960,"startTime":"0","endTime":"0","summary":"2025年,在水泥行业需求持续趋弱、价格承压的背景下,海螺水泥(600585)净利润实现过去5年来首次正增长。3月24日,海螺水泥披露最新年报,公司2025年实现营收825.32亿元,同比下降9.33%;净利润81.13亿元,同比增长5.42%。公司表示,报告期内,受主营产品价格下降影响,公司主营收入同比下降6.39%,但受益于运营效率提升和成本压降,净利润同比上升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603253684457949.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253684457949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","BK0188","LU1328615791.USD","BK0235","BK1507","BK1594","BK0012","BK1505","BK0044","BK1135","BK0187","BK1563","BK1583","BK0196","600585","BK0183","BK0015","00914"],"gpt_icon":0},{"id":"2622507793","title":"融創服務:2026年6月9日派發股息0.01元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622507793","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622507793?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 22:45","pubTimestamp":1774449900,"startTime":"0","endTime":"0","summary":"南财智讯3月25日电,融创服务(01516.HK)公告,公司宣布截至2025年12月31日止年度的末期股息,每股派发现金股息0.01元(人民币),股息派发日为2026年6月9日;除净日为2026年5月27日;股东登记截止时间为2026年5月28日16:30;暂停办理股份过户登记手续日期为2026年5月29日至6月2日;记录日期为2026年6月2日。本次股息无需代扣所得税。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253684458695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1229","01516","VIG","BK4588","BK1583","BK4585","BK1258","BK1585","BK1542"],"gpt_icon":0},{"id":"2622077878","title":"融創服務(01516)發布年度業績 股東應占利潤2.03億元 按年扭虧為盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2622077878","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622077878?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 22:43","pubTimestamp":1774449800,"startTime":"0","endTime":"0","summary":"智通财经APP讯,融创服务 发布截至2025年12月31日止年度业绩,该集团期内取得收入68.16亿元,同比减少2.2%;公司拥有人应占利润2.03亿元,同比扭亏为盈;每股基本盈利0.07元;拟派发末期股息每股0.01元。截至2025年12月31日止年度,本集团的物业管理及运营服务收入约63.64亿元,较截至2024年12月31日止年度减少约1570万元, 主要由于本集团的附属公司彰泰服务自2025年8月之后不再纳入本集团综合财务报表的合并范围之内所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"融创服务(01516)发布年度业绩 股东应占利润2.03亿元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1258","01516","BK1583","BK1229","BK1542","BK1585"],"gpt_icon":0},{"id":"2622072988","title":"沛嘉醫療-B(09996)發布年度業績 收入按年增長15.82%至7.13億元 神經介入業務分部利潤按年大幅增長86.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622072988","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622072988?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 22:23","pubTimestamp":1774448601,"startTime":"0","endTime":"0","summary":"智通财经APP讯,沛嘉医疗-B 发布截至2025年12月31日止年度业绩,该集团取得收入7.13亿元,同比增长15.82%;股东应占亏损同比收窄10.28%;每股基本亏损0.31元。报告期内,集团实现收入人民币7.13亿元,同比增长15.82%。神经介入业务分部利润同比增长86.6%至人民币9720万元,而经导管瓣膜治疗业务分部亏损同比收窄20.2%至人民币2.16亿元。若剔除前沿技术业务组成实体应占的亏损,集团年度经调整亏损将为人民币1.11亿元,同比收窄44.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419071.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","159891","BK1100","09996"],"gpt_icon":0},{"id":"1194672043","title":"沛嘉醫療-B:2026年或成集團神經介入業務全球化擴張的起點","url":"https://stock-news.laohu8.com/highlight/detail?id=1194672043","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194672043?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 22:15","pubTimestamp":1774448130,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B预计,2026年将成为集团在神经介入业务领域迈向全球市场布局的初步阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","BK1574","09996"],"gpt_icon":0},{"id":"2622071764","title":"3月25日海螺水泥發布公告,股東增持3475.56萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622071764","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622071764?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 21:42","pubTimestamp":1774446159,"startTime":"0","endTime":"0","summary":"证券之星消息,3月25日海螺水泥发布公告《海螺水泥:关于控股股东权益变动触及1%刻度的提示性公告》,其股东安徽海螺集团有限责任公司于2026年3月3日至2026年3月25日间合计增持3475.56万股,占公司目前总股本的0.6559%,变动期间该股股价下跌10.47%,截止3月25日收盘报23.34元。股东增减持详情见下表: 根据海螺水泥2025年年报公布的十大股东详情如下: 为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/25/20260325434449.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/25/20260325434449.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260325/32098580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0015","BK0196","BK1135","BK1507","BK0183","BK0235","BK1583","BK0044","00914","BK1594","BK0012","BK0187","BK0028","600585","BK0188","LU1328615791.USD","BK1505","BK1563"],"gpt_icon":0},{"id":"2622071591","title":"李氏大藥廠(00950):茵若颯取得國家藥監局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2622071591","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622071591?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 21:37","pubTimestamp":1774445826,"startTime":"0","endTime":"0","summary":"智通财经APP讯,李氏大药厂(00950)发布公告,于2026年3月17日,中国国家药品监督管理局(国家药监局)已批准茵若飒(由Cosette Pharmaceuticals拥有并已授予李氏大药厂许可)用于治疗具有中重度症状(不包括泌尿系症状)的绝经后女性外阴阴道萎缩。继本公司全资附属公司兆科药业(合肥)有限公司进行的第III期、多中心、随机、双盲、平行对照临床试验成功完成后,是次获批标志着一个重要的里程碑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06622","BK1574","BK1191","BK1587","BK1583","00950"],"gpt_icon":0},{"id":"2622078438","title":"兆科眼科-B(06622)公布2025年業績 税後虧損約2.09億元 按年收窄12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078438","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078438?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 19:46","pubTimestamp":1774439191,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兆科眼科-B(06622)公布2025年业绩,收益3197.4万元,同比减少53.88%;税后亏损约2.09亿元,同比收窄12%。公告称,亏损减少主要源于集团继续严格控制行政费用及销售及分销开支,反映年内成本控制有所加强及营运架构效率提升。此外,研发开支随着若干主要开发里程碑达成而有所减少,并无如上一年度产生非经常性开支亦进一步推动改善。尽管并无如上一年度取得一次性的许可收入,且2025年利率下调令银行利息收入减少,惟集团取得的年内亏损仍然实质收窄。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1583","BK1191","06622","BK1587"],"gpt_icon":0},{"id":"2622078184","title":"Zhaoke Ophthalmology FY2025; revenue drops to CNY 32 million due to lower one-off license income","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078184","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078184?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 19:43","pubTimestamp":1774439016,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology reported regulatory milestones that could expand its near-term commercial portfolio, led by three flagship assets positioned for large ophthalmology markets in China and internationally.In China, 国家药监局 accepted the biological products license application for 贝伐单抗玻璃体腔内注射液 , supporting a potential first-mover position in a wAMD-focused bevacizumab filing.In the US, FDA approved the new drug investigational application for 环孢素眼用凝胶 to start a Phase III trial, which could strengthen partnering options and broaden the addressable market beyond Greater China.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhaoke Ophthalmology Ltd. published the original content used to generate this news brief via IIS, the Issuer Informat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL94t3zx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1574","06622","BK1583","BK1587"],"gpt_icon":0},{"id":"2622078167","title":"「三甲」之後,險資辦醫的「下半場」:不拼床位拼什麼?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078167","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078167?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 19:38","pubTimestamp":1774438707,"startTime":"0","endTime":"0","summary":"近期,泰康仙林鼓楼医院获评“三甲”医院,这既是对该医院医疗实力的肯定,也是险资在医养结合方面探索的成果。近几年,人口老龄化加速、健康中国战略持续推进,叠加行业转型攻坚,医疗产业正成为保险机构布局的“核心赛道”。数据显示,截至2025年末,保险资金已通过直接或间接方式,向医疗康养产业投入超4000亿元资金,其中各类医院、康复机构及综合医疗体成为布局焦点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603253684256620.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603253684256620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06078","LU0737861772.HKD","LU0329678170.USD","LU2488822045.USD","LU0329678337.USD","BK1583","BK1209"],"gpt_icon":0},{"id":"2622078523","title":"歸創通橋(02190)3月25日耗資約189.24萬港元回購7.9萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078523","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078523?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 19:34","pubTimestamp":1774438449,"startTime":"0","endTime":"0","summary":"智通财经APP讯,归创通桥(02190)公布,2026年3月25日耗资约189.24万港元回购7.9万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","02190","BK1100","BK1587","BK1574"],"gpt_icon":0},{"id":"2622002020","title":"泰凌醫藥(01011)完成收購浙江康源醫療器械58.11%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=2622002020","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622002020?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 19:21","pubTimestamp":1774437695,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰凌医药 发布公告,就有关公司拟约1.16亿元收购浙江康源医疗器械58.11%股权的相关事宜。公司已于2026年3月25日按每股代价股份0.45港元的发行价向8名卖方发行及配发2.75亿股新股份以完成支付代价,通函“先决条件”分节所载买卖协议及补充协议的所有先决条件已获达成。收购事项完成后,公司透过全资附属公司间接持有浙江康源医疗器械有限公司58.11%股权,其财务业绩将于集团账目内综合入账。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418900.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1100","01011","09996","BK1574","09997","BK1222","BK1583","BK1191"],"gpt_icon":0},{"id":"2622020772","title":"仁橋(北京)資產管理有限公司增持紅星美凱龍(01528)756.28萬股 每股作價約1.24港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622020772","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622020772?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 19:15","pubTimestamp":1774437326,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,3月23日,二桥(北京)资产管理有限公司增持红星美凯龙(01528)756.28万股,每股作价1.2355港元,总金额约为934.38万港元。增持后最新持股数目为8169.06万股,最新持股比例为11.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1229","BK1542","BK1258","BK1501","01528","BK1583","09983"],"gpt_icon":0},{"id":"2622020093","title":"執行董事龍振國增持德琪醫藥(06996)23.5萬股 每股作價約4.14港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622020093","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622020093?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 19:14","pubTimestamp":1774437259,"startTime":"0","endTime":"0","summary":"香港联交所最新数据显示,3月24日,执行董事龙振国增持德琪医药(06996)23.5万股,每股作价4.136港元,总金额约为97.2万港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260325/20260325191438_18992.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260325/20260325191438_18992.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"执行董事龙振国增持德琪医药(06996)23.5万股 每股作价约4.14港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","06996","BK1191","BK1583"],"gpt_icon":0},{"id":"2622027671","title":"資金動向 | 北水淨買入港股223億港元,大手筆加倉泡泡瑪特、美團和阿里","url":"https://stock-news.laohu8.com/highlight/detail?id=2622027671","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622027671?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 18:51","pubTimestamp":1774435881,"startTime":"0","endTime":"0","summary":"跟踪南向资金最新动态","market":"sh","thumbnail":"https://img3.gelonghui.com/b0b29-dcad8099-8be5-4e08-b1a6-3f09b3ab02c5.jpg?guru_height=2170&guru_width=3872&guru_size=617454","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/b0b29-dcad8099-8be5-4e08-b1a6-3f09b3ab02c5.jpg?guru_height=2170&guru_width=3872&guru_size=617454"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4185443","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0345775950.USD","LU1823568750.SGD","LU0251143458.SGD","LU0211977185.USD","LU1102505929.USD","LU1328277881.USD","LU1868837565.USD","LU2226246903.HKD","LU2152927971.USD","LU2097828474.EUR","LU0348735423.USD","BK4220","LU0320764599.SGD","SG9999014674.SGD","LU0164872284.USD","BABU","LU2087589342.USD","SG9999001903.USD","BK4502","LU0541501648.USD","IE00B3M56506.USD","LU0593848301.USD","IE00B5MMRT66.SGD","LU0214875030.USD","BK1604","LU0828237940.HKD","LU1993786604.SGD","LU0029875118.USD","LU0871576103.HKD","IE0032431581.USD","LU0819123356.HKD","LU1242518857.USD","LU0084288322.USD","LU0456827905.SGD","LU0049853897.USD","BBYY","LU2097828805.USD","LU2242644610.SGD","LU0577902538.SGD","BK4543","IE00BPRC5H50.USD","LU0128525689.USD","LU0823040885.USD","LU0052756011.USD","LU0287142896.SGD","LU0634319403.HKD","LU1880383440.USD","LU0210526637.USD","LU0456846285.SGD","LU0310800965.SGD","LU0589944569.HKD","LU1008478684.HKD","LU1267930227.SGD","BK4535","LU1303224171.USD","BK4565","LU1880383366.USD","LU1105468828.SGD","LU0588545490.SGD","LU0878005551.USD","LU0039217434.USD","LU0307460666.USD","BK4209","BK4527","LU0149721374.USD","BK4585","LU0633140727.USD","LU0819121731.USD","LU1152091754.HKD","LU1794554557.SGD","LU2045819591.USD","LU0531971595.HKD","LU0143863784.USD","BK1591","LU0543330483.HKD","LU2148510915.USD","LU0577902454.USD","LU0738911758.USD","LU0918141887.USD","LU0949170772.SGD","PMRTY","LU0821914370.USD","BK4533","LU1770034418.SGD","LU0449515922.USD","LU0541502299.USD","LU0244354667.USD","LU0231483743.USD","LU0828238088.HKD","LU1003077747.HKD","LU0737861699.HKD","BK1610","LU1226287529.USD","LU0181495838.USD","LU0417516902.SGD","LU0572944931.SGD","BK4534","BABX","09992","LU0106959298.USD","LU0868486357.SGD","SG9999001069.SGD","09988","LU0456842615.SGD","BABA","LU1188198961.HKD","SGXZ62798434.SGD","LU0261950983.USD","LU1048588211.SGD","IE00B031HY20.USD","HMTD.SI","BK4588","LU0054450605.USD","LU0326950275.SGD","LU2148611432.USD","LU0633140560.USD","LU2399975544.HKD","LU0359202008.SGD","SGXZ86797644.SGD","LU0417516738.SGD","LU1323998911.USD","BK4538","LU1769817096.USD","LU0327786744.USD","LU1808992512.USD","LU1051769294.HKD","LU0348766576.USD","LU1046422090.SGD","LU1868838027.USD","LU0918141705.HKD","LU1046421795.USD","LU2476274720.SGD","LU1868837722.USD","BABO","LU0463099449.HKD","LU0979878070.USD","IE00BFMHRM44.USD","BK4607","BK1615","BK4505","LU0501845795.SGD","LU0011963245.USD","LU0345776255.USD","LU0359201885.HKD","LU0502904849.HKD","LU1770036033.HKD","LU0072462343.USD","LU1961090484.USD","BK1583","LU0856984785.SGD","LU0577902371.SGD","LU1242518931.SGD","IE00B0JY6N72.USD","LU0873338254.USD","LU0228659784.USD","BK4614","IE00B543WZ88.USD","LU0269904917.USD","LU0328353924.USD","LU0348788117.USD","LU0540923850.HKD","LU1734074674.USD","LU2097828714.EUR","LU2125910500.SGD","LU0173614495.USD","LU0588545904.SGD","LU1807302812.USD","BK4122","LU1064131003.USD","03690","LU1102505762.USD","IE0034224299.USD","LU1235294995.USD","LU1282648689.USD","IE0008369823.USD","LU1769817179.HKD","BK4587","LU0553294199.USD","LU0052750758.USD","LU0072913022.USD","BK4554","KBAB","LU0143863198.USD","LU0348814723.USD","LU0828237510.HKD","BK4558","LU0823426308.USD","LU2097828557.USD","LU0048580855.USD","IE0008368742.USD","LU0315178854.USD","LU0865486749.SGD","LU1224709979.USD","SG9999002828.SGD","LU0128522157.USD","LU1051768304.USD","LU0594300419.USD","LU0499858438.USD","LU0880133367.SGD","LU1023057109.AUD","LU0823038988.USD","LU1960683339.HKD","LU2097828631.EUR","LU2257852520.SGD","LU0048597586.USD","LU0348827113.USD","LU1481107354.HKD","BK4548","BK1224","LU0051755006.USD","LU0140636845.USD","LU0650527681.SGD","LU2778985437.USD","LU0348805143.USD","SG9999001689.USD","BK1142","IE00B29SXG58.USD","LU0047713382.USD","LU0449509016.USD","LU0577902298.EUR","LU0196878994.USD","LU0588546209.SGD","LU0823039010.USD","LU0251144936.SGD","LU0431992006.USD","LU0509642566.USD","LU0594300179.USD","LU0348825331.USD","LU1048596156.SGD","LU2039709279.SGD","LU2543165471.USD","IE00BF5LJ272.USD","LU0164880469.USD","LU0117841782.USD","LU0370786039.SGD","LU1251922891.USD","LU1675838814.USD","LU0067412154.USD","LU0164865239.USD","BK1589","LU0683595622.HKD","LU1720050803.USD","SG9999002463.SGD","LU0672654166.SGD","BK1233","LU1515016050.SGD","SG9999002562.SGD","LU1813983027.USD","LU0823041008.USD","LU0823426480.USD","LU1328615791.USD","LU0348767384.USD","LU0348816934.USD","BK1618","LU0577902611.USD","LU0455707207.USD","LU0561508036.HKD","LU1152091168.USD","LU1831875114.USD","LU0651946864.USD","LU0661504455.SGD","BK4581","SG9999000459.SGD","LU1719994722.HKD","LU0797268264.HKD","BK4526","BK4575","LU0700851271.USD","LU0499858602.USD","BK1575","LU0106252389.USD","LU0326948709.USD","LU0588545730.USD","BK4504","BK4503","LU0651947912.USD","LU0545039389.USD","BABW","BK4579","LU0054237671.USD","LU0314109678.HKD","LU0611395673.USD","LU2488822045.USD","LU0359201612.USD","LU0043850808.USD","LU0320764755.SGD","LU0605514214.HKD","LU1688375341.USD","LU0708995583.HKD","BK4531","BK4524","MPNGY","LU0132412106.USD","LU2476274308.USD","SG9999002950.SGD","BK1521","SG9999000327.SGD","LU0165289439.USD","LU1064130708.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":23,"pageCount":1,"totalSize":455,"code":"91000000","status":"200"}]}}